Atrial fibrillation, or Afib, is the most common type of heart arrhythmia. Afib increases your risk of heart attack and ...

A recent discussion with BDO's clinical trials editor and Audrey Davis of CSC, discussed strategies to increase clinical ...

Results for the Phase I clinical trial, published in the New England Journal of Medicine, bring hope for people with ...

A patient with small cell lung cancer shared her clinical trial experience with CURE® and how she encourages other patients ...

The National Institutes of Health (NIH) has unveiled a new artificial intelligence (AI) algorithm designed to more ...

Ocugen has announced positive Phase 1 trial results for OCU410, a one-time gene therapy for geographic atrophy secondary to ...

Regeneron’s clinical trials are at the core of this mission. Regeneron is grateful to all clinical trial participants — ...

An AI tool called Muse aims to optimize clinical trial patient recruitment and accelerate the development of new therapies.

A revolutionary breakthrough in cataract treatment is on the horizon, with the emergence of C-KAD, a new eye drop therapy.

Researchers from the National Institutes of Health (NIH) have developed an artificial intelligence (AI) algorithm to help ...

Medable is bringing generative AI into its clinical trial platform in hopes that the tech will reduce the burden of ...

A Phase 2 trial testing oral ROCK inhibitor Bravyl in people with ALS is now fully enrolled at its highest dosing group.